A Study to Collect Information on the Characteristics of Elderly Belgian Patients With NVAF That Are Treated With a NOAC for This Indication With a Special Focus on Their Fear of Bleeding While Using a NOAC vs the Clinical Benefit of a NOAC of Thrombosis/Stroke Prevention.
Clinical trial NCT04722679 · COMPLETED
Trial details
- NCT number
- NCT04722679
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-05-11
- Primary completion
- 2021-12-31
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.